RC
CELG

RegentAtlantic Capital’s Celgene Corp CELG Stock Holding History

RegentAtlantic Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32,271
Closed -$3.21M – 478
2019
Q3 		$3.21M Sell
32,271
-14
-0% -$1.33K 0.21% 120
2019
Q2 		$2.98M Sell
32,285
-934
-3% -$88.7K 0.2% 123
2019
Q1 		$3.13M Sell
33,219
-1,218
-4% -$107K 0.22% 113
2018
Q4 		$2.21M Sell
34,437
-12
-0% -$886 0.19% 131
2018
Q3 		$3.08M Buy
34,449
+1,005
+3% +$88.8K 0.24% 109
2018
Q2 		$2.66M Buy
33,444
+11,935
+55% +$991K 0.23% 115
2018
Q1 		$1.92M Buy
21,509
+397
+2% +$38.1K 0.16% 148
2017
Q4 		$2.2M Buy
21,112
+406
+2% +$45.8K 0.18% 134
2017
Q3 		$3.02M Sell
20,706
-244
-1% -$33.2K 0.26% 110
2017
Q2 		$2.72M Hold
20,950
– – 0.25% 117
2017
Q1 		$2.61M Sell
20,950
-376
-2% -$45K 0.24% 115
2016
Q4 		$2.47M Sell
21,326
-5,155
-19% -$574K 0.24% 111
2016
Q3 		$2.77M Sell
26,481
-671
-2% -$72.6K 0.29% 94
2016
Q2 		$2.68M Sell
27,152
-551
-2% -$57K 0.26% 95
2016
Q1 		$2.77M Buy
27,703
+2,713
+11% +$279K 0.31% 82
2015
Q4 		$2.99M Buy
24,990
+1,064
+4% +$123K 0.32% 88
2015
Q3 		$2.59M Sell
23,926
-2,655
-10% -$329K 0.25% 101
2015
Q2 		$3.08M Sell
26,581
-12
-0% -$1.37K 0.27% 94
2015
Q1 		$3.07M Sell
26,593
-503
-2% -$60.1K 0.27% 101
2014
Q4 		$3.03M Sell
27,096
-854
-3% -$90.1K 0.26% 99
2014
Q3 		$2.65M Buy
27,950
+638
+2% +$57.6K 0.25% 104
2014
Q2 		$2.35M Buy
27,312
+652
+2% +$49.6K 0.22% 108
2014
Q1 		$1.86M Buy
26,660
+768
+3% +$60.8K 0.18% 120
2013
Q4 		$2.19M Sell
25,892
-292
-1% -$23.1K 0.21% 116
2013
Q3 		$2.02M Buy
26,184
+552
+2% +$38.7K 0.22% 115
2013
Q2 		$1.5M Buy
+25,632
New +$1.54M 0.18% 128

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

RegentAtlantic Capital's CELG Position: Q4 2019 in Review

RegentAtlantic Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 32,271 shares — an estimated $3.21M sold.

RegentAtlantic Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.21M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RegentAtlantic Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RegentAtlantic Capital sold 32,271 Celgene Corp shares in Q4 2019, an estimated $3.21M.
  • RegentAtlantic Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • RegentAtlantic Capital's Celgene Corp position peaked at $3.21M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RegentAtlantic Capital's 13F filing for Q4 2019, filed 4 Feb 2020.